Senior / Medical Science Liaison (Houston-area, TX or Great Lakes MI/IN/OH/PA) #4291

Texas, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Medical DevicesIndustries

Requirements

Candidates should possess an advanced scientific degree such as a PhD, PharmD, MD, NP, PA, or CGC, with preference given to those with experience in oncology, genomics, diagnostics, or cfDNA-based fields, and a minimum of two years of external-facing experience in a diagnostics or pharmaceutical Medical Affairs setting. Strong knowledge of the biotechnology, diagnostics, and/or pharmaceutical industry is preferred, along with the ability to apply advanced knowledge of GRAIL’s product specifications.

Responsibilities

The Senior/Medical Science Liaison will develop and maintain strong educational and collaborative relationships with key primary care providers, diagnostic specialists, KOLs, oncologists, and HCS decision makers to support understanding and adoption of the Galleri MCED Test. They will provide necessary and appropriate medical education through slides, abstracts, and publications, respond to unsolicited questions, participate in the development of educational resources, and train external speakers. This role also involves ensuring all interactions adhere to compliance guidelines, supporting ordering providers with post-positive patient journey support, summarizing complex medical messages, eliciting insights, and participating in local, regional, and national meetings to achieve scientific and medical objectives.

Skills

Medical Education

Scientific Communication

KOL Engagement

Clinical Support

Educational Resource Development

Training External Speakers

GRAIL

Develops blood tests for early cancer detection

About GRAIL

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$1,765.5MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

Risks

Potential overdiagnosis could impact the perceived value of GRAIL's tests.

Significant net losses may affect investor confidence and long-term sustainability.

High test costs may limit accessibility in markets with less healthcare funding.

Differentiation

GRAIL uses high-intensity sequencing for early cancer detection via blood tests.

The Galleri test screens for over 50 cancers with a single blood draw.

GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Upsides

Collaborations with platforms like Function Health expand Galleri test accessibility.

Revenue from Galleri grew 52% year-over-year, indicating strong market demand.

GRAIL's technology aligns with trends in personalized and preventative medicine.

Land your dream remote job 3x faster with AI

Try Jobo Free